| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Pharmaceuticals& Drugs | 837.4 |
21 (2.57%) |
Small Cap | 6,672 | 34.3 | 8.29 | 23.8 | 2.8 | |
| Piramal Pharma | Pharmaceuticals& Drugs | 177.1 |
5.2 (3.03%) |
Small Cap | 4,782 | 5.3 | 10.29 | 32.7 | 2.8 | |
| Natco Pharma | Pharmaceuticals& Drugs | 983.6 |
22.1 (2.3%) |
Small Cap | 4,430 | 79.2 | 40.5 | 12.1 | 1.9 | |
| Emcure Pharma | Pharmaceuticals& Drugs | 1,810.5 |
2.65 (0.15%) |
Small Cap | 4,382 | 38.6 | 6.24 | 46.8 | 9.2 | |
| Gland Pharma | Pharmaceuticals& Drugs | 2,479.7 |
10.65 (0.43%) |
Small Cap | 4,116 | 78.8 | 26.26 | 31.3 | 3.8 | |
| JB Chem & Pharma | Pharmaceuticals& Drugs | 2,437.7 |
-3.3 (-0.14%) |
Small Cap | 3,890 | 42 | 17.14 | 58.1 | 9.7 | |
| Global Health | Hospital &HealthcareServices | 1,336.7 |
-10.4 (-0.77%) |
Small Cap | 3,204 | 18.5 | 15.48 | 73 | 9 | |
| Granules India | Pharmaceuticals& Drugs | 889.6 |
8.4 (0.95%) |
Small Cap | 3,030 | 16.2 | 9.87 | 54.5 | 5 | |
| Wockhardt | Pharmaceuticals& Drugs | 1,811.5 |
-18.9 (-1.03%) |
Small Cap | 3,012 | 13.1 | -1.8 | 139.6 | 6 | |
| Eris Lifesciences | Pharmaceuticals& Drugs | 1,428.7 |
-2.7 (-0.19%) |
Small Cap | 2,894 | 44.7 | 12.9 | 32 | 5.1 | |
| Dishman Carbogen Amc | Pharmaceuticals& Drugs | 195.8 |
3.15 (1.64%) |
Small Cap | 2,712 | 6.2 | 0.85 | 31 | 0.5 | |
| Dr. Lal Pathlabs | Hospital &HealthcareServices | 1,692.9 |
8.6 (0.51%) |
Small Cap | 2,648 | 30.3 | 19.83 | 55.6 | 11.7 | |
| Pfizer | Pharmaceuticals& Drugs | 4,728.6 |
128.05 (2.78%) |
Small Cap | 2,520 | 157.9 | 30.02 | 29.1 | 5 | |
| Aarti Drugs | Pharmaceuticals& Drugs | 396.4 |
0.65 (0.16%) |
Small Cap | 2,387 | 21.4 | 7.04 | 18.5 | 2.3 | |
| Alivus Life Sciences | Pharmaceuticals& Drugs | 1,160.5 |
18 (1.58%) |
Small Cap | 2,387 | 46 | 20.07 | 24.8 | 4.2 | |
| Strides Pharma Scien | Pharmaceuticals& Drugs | 1,081.8 |
7.95 (0.74%) |
Small Cap | 2,139 | 19.9 | 2.46 | 53.9 | 3 | |
| IOL Chem & Pharma | Pharmaceuticals& Drugs | 171.1 |
3.05 (1.81%) |
Small Cap | 2,079 | 4.7 | 4.59 | 35.8 | 2.7 | |
| FDC | Pharmaceuticals& Drugs | 432 |
0.15 (0.03%) |
Small Cap | 2,070 | 17.6 | 12.16 | 24.6 | 2.8 | |
| Caplin Point Labs. | Pharmaceuticals& Drugs | 2,585.4 |
-35 (-1.34%) |
Small Cap | 1,937 | 84.4 | 27.17 | 31.1 | 5.6 | |
| Hikal | Pharmaceuticals& Drugs | 244.8 |
11.35 (4.86%) |
Small Cap | 1,860 | -4 | 4.72 | - | 2.4 | |
| Sanofi India | Pharmaceuticals& Drugs | 3,410.6 |
55.15 (1.64%) |
Small Cap | 1,837 | 134.5 | 18.75 | 24.9 | 9.9 | |
| Aarti Pharmalabs | Pharmaceuticals& Drugs | 709 |
6.95 (0.99%) |
Small Cap | 1,771 | 19.4 | 14.41 | 36.1 | 3.2 | |
| Astrazeneca Pharma | Pharmaceuticals& Drugs | 8,123.9 |
12.5 (0.15%) |
Small Cap | 1,716 | 75 | 10.69 | 108.1 | 23.2 | |
| Dr. Agarwals Health | Hospital &HealthcareServices | 483.4 |
-1.6 (-0.33%) |
Small Cap | 1,711 | 4.2 | 5.97 | 115.4 | 7.6 | |
| Nectar Lifesciences | Pharmaceuticals& Drugs | 11.2 |
-0.02 (-0.18%) |
Small Cap | 1,670 | -3 | -7.17 | - | 0.4 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: